Regulon

Regulon: R-1041

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
122.2405712Pr-140Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3693 ENSG00000082781 ITGB5 P18084
768 ENSG00000107159 CA9 Q16790
24145 ENSG00000110218 PANX1 A0A024R397
6675 ENSG00000117143 UAP1 Q16222
23213 ENSG00000137573 SULF1 Q8IWU6
8444 ENSG00000143479 DYRK3 O43781
5352 ENSG00000152952 PLOD2 O00469
9903 ENSG00000162413 KLHL21 Q9UJP4
2669 ENSG00000164949 GEM P55040
55048 ENSG00000167987 VPS37C A5D8V6
6526 ENSG00000198743 SLC5A3 P53794
4363 ENSG00000278183 ABCC1 A0A0A0MS99

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
SULTHIAMECA2Small moleculeINHIBITORCarbonic anhydrase inhibitor40
CILENGITIDEITGAVProteinANTAGONISTIntegrin alpha-V/beta-3 antagonist33
CG250 177LUCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
GIRENTUXIMABCA9AntibodyOTHERCarbonic anhydrase IX other30
CG250 111INCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
INTETUMUMABITGAVAntibodyANTAGONISTIntegrin alpha-V/beta-3 antagonist20
ABITUZUMABITGAVAntibodyINHIBITORIntegrin alpha-V/beta-5 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1041

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-17431LGALS8up-regulatesCEBPGactivatesR-1041232Drugs (7)
CMF-23340CCDC132up-regulatesCEBPGactivatesR-1041232Drugs (7)